Google Parent Alphabet Apologizes For Cloud Computing Outage
Google parent company Alphabet (GOOGL) has apologized for a major outage of its cloud computing network that disrupted users worldwide.The Silicon Valley-based technology giant said the outage that occurred on June 12 was caused by multiple layers of flawed recent updates. In all, more than 70 Google cloud services stopped working worldwide, knocking down or disrupting dozens of third-party services, including Cloudflare (NET) and Shopify (SHOP). Several Google products, including Gmail, Google Drive, and Google Meet malfunctioned for several hours during the cloud disruption. Now, Alphabet has issued a formal apology, saying: “We deeply apologize for the impact this outage has had… Google Cloud customers and their users trust their businesses to Google, and we will do better.”In May, Alphabet added a new feature to its quota policy checks for evaluating automated incoming requests, but the new feature wasn’t tested in real-world situations. As a result, the systems didn’t know how to properly handle data, leading to the cloud crash.While engineers at Alphabet figured out the problem 10 minutes into the crash, the incident lasted for seven hours. Going forward, the company said that it will change its architecture so if one system fails, it can still operate without crashing. Google said it will also audit all systems and improve its communications. GOOGL stock is down 7% this year and currently trading at $176.77 U.S. per share.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


